These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 3001760)
1. Opiate receptor activity of 17-alpha-estradiol and related steroids. LaBella FS Prog Clin Biol Res; 1985; 192():323-8. PubMed ID: 3001760 [TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin analogues and 17-alpha-dihydroequilin on rat brain opiate receptors. Pugsley TA; Lippmann W Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):153-6. PubMed ID: 210485 [TBL] [Abstract][Full Text] [Related]
3. [Alpha interferon interaction with opiate receptors in the rat brain]. Panchenko LF; Aliab'eva TN; Malinovskaia VV; Balashov AM Biull Eksp Biol Med; 1987 Jul; 104(7):87-9. PubMed ID: 3040148 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens. Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952 [TBL] [Abstract][Full Text] [Related]
5. The effects of estradiol and progesterone on pain sensitivity and brain opioid receptors in ovariectomized rats. Gordon FT; Soliman MR Horm Behav; 1996 Sep; 30(3):244-50. PubMed ID: 8918680 [TBL] [Abstract][Full Text] [Related]
7. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin. Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160 [TBL] [Abstract][Full Text] [Related]
8. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. Tao PL; Law PY; Loh HH J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275 [TBL] [Abstract][Full Text] [Related]
9. The effect of 17-alpha-estradiol, a possible endogenous opiate antagonist, on D-ala2-met5-enkephalinamide-induced blood pressure responses in conscious, unrestrained rats. Chandra A; Dixon WR NIDA Res Monogr; 1986; 75():339-42. PubMed ID: 3123948 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286 [TBL] [Abstract][Full Text] [Related]
12. [Comparative activity of endorphins on the opiate receptors]. Vallée E; Chambon JP; Delahayes J C R Acad Hebd Seances Acad Sci D; 1977 Jul; 285(3):257-60. PubMed ID: 198160 [TBL] [Abstract][Full Text] [Related]
13. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure. Jordan VC; Lieberman ME Mol Pharmacol; 1984 Sep; 26(2):279-85. PubMed ID: 6541293 [TBL] [Abstract][Full Text] [Related]
14. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. Geary WA; Wooten GF J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375 [TBL] [Abstract][Full Text] [Related]
15. Beta-Endorphin. Opiate receptor-binding activity of synthetic analogs modified in the enkephalin segment in rat brain membrane and neuroblastoma x glioma hybrid cell. Hammonds RG; Li CH Int J Pept Protein Res; 1982 Mar; 19(3):254-8. PubMed ID: 6288587 [TBL] [Abstract][Full Text] [Related]
16. [Interaction of thymosin fraction 3 with opiate receptors]. Zozulia AA; Khomiakov IuN; Bezvershenko IA Biull Eksp Biol Med; 1986 Mar; 101(3):298-300. PubMed ID: 3006826 [TBL] [Abstract][Full Text] [Related]
17. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype. Karkanias GB; Etgen AM Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407 [TBL] [Abstract][Full Text] [Related]
18. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation. Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808 [TBL] [Abstract][Full Text] [Related]